Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MLH1 mutation
i
Other names:
MLH1, COCA2, FCC2, HNPCC, HNPCC2, MutL homolog 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4292
Related biomarkers:
Mutation
CNA
Others
‹
›
Associations
(6)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Researching the Effect of Aerobic Exercise on Cancer (NCT03996239)
Phase N/A
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Recruiting
Phase N/A
Memorial Sloan Kettering Cancer Center
Recruiting
Last update posted :
06/14/2024
Initiation :
06/20/2019
Primary completion :
06/01/2024
Completion :
06/01/2024
MLH1 • MSH6 • MSH2 • EPCAM
|
MSH2 mutation • MLH1 mutation • PMS2 mutation
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome (NCT04379999)
Phase 1
Fox Chase Cancer Center
Fox Chase Cancer Center
Recruiting
Phase 1
Fox Chase Cancer Center
Recruiting
Last update posted :
06/13/2024
Initiation :
09/10/2018
Primary completion :
12/31/2024
Completion :
12/31/2024
MLH1 • MSH6 • MSH2 • EPCAM • CASP3
|
MSH2 mutation • MLH1 mutation • PMS2 mutation
|
atorvastatin
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair (NCT02912559)
Phase 3
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Active, not recruiting
Phase 3
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
06/07/2024
Initiation :
10/16/2017
Primary completion :
04/02/2025
Completion :
04/02/2025
MLH1 • MSH6 • MSH2 • CD4
|
MSI-H/dMMR • MSH2 mutation • MLH1 mutation • PMS2 mutation • MSH6 expression
|
Tecentriq (atezolizumab) • Zelboraf (vemurafenib) • 5-fluorouracil • Cotellic (cobimetinib) • oxaliplatin • leucovorin calcium • fluorouracil topical
Pancreatic Cancer Early Detection Program (PCEDP) (NCT02206360)
Phase N/A
White Plains Hospital
White Plains Hospital
Active, not recruiting
Phase N/A
White Plains Hospital
Active, not recruiting
Last update posted :
05/24/2024
Initiation :
04/01/2014
Primary completion :
03/01/2024
Completion :
06/01/2024
BRCA1 • BRCA2 • CDKN2A • MLH1 • MSH6 • MSH2 • EPCAM • PRSS1
|
TP53 mutation • BRCA1 mutation • PALB2 mutation • CDKN2A mutation • MSH2 mutation • MLH1 mutation • PMS2 mutation
Nivolumab in Biochemically Recurrent dMMR Prostate Cancer (NCT04019964)
Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Cent...
Recruiting
Phase 2
Sidney Kimmel Comprehensive Cancer Center at Jo...
Recruiting
Last update posted :
04/26/2024
Initiation :
01/13/2020
Primary completion :
01/01/2025
Completion :
01/01/2025
TMB • MSI • MLH1 • MSH6 • MSH2 • CDK12
|
MSI-H/dMMR • CDK12 mutation • MSH2 mutation • MLH1 mutation
|
Opdivo (nivolumab)
Quebec Pancreas Cancer Study (QPCS) (NCT04104230)
Phase N/A
George Zogopoulos
George Zogopoulos
Recruiting
Phase N/A
George Zogopoulos
Recruiting
Last update posted :
04/17/2024
Initiation :
03/12/2012
Primary completion :
01/01/2025
Completion :
01/01/2025
BRCA1 • BRCA2 • ATM • STK11 • CDKN2A • MLH1 • MSH6 • MSH2 • EPCAM • PRSS1
|
ATM mutation • STK11 mutation • PALB2 mutation • CDKN2A mutation • MSH2 mutation • MLH1 mutation • PMS2 mutation
Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients (NCT05078866)
Phase 1/2
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Recruiting
Phase 1/2
National Cancer Institute (NCI)
Recruiting
Last update posted :
04/15/2024
Initiation :
11/10/2022
Primary completion :
07/31/2025
Completion :
07/31/2025
BRAF • MSI • MLH1 • MSH6 • MSH2
|
BRAF mutation • MSH2 mutation • MLH1 mutation • PMS2 mutation
|
NOUS-209
Pancreatic Cancer Screening for At-risk Individuals (PancreasScan) (NCT05006131)
Phase N/A
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
Recruiting
Phase N/A
Beth Israel Deaconess Medical Center
Recruiting
Last update posted :
03/19/2024
Initiation :
07/10/2020
Primary completion :
03/10/2027
Completion :
03/10/2028
BRCA1 • BRCA2 • ATM • STK11 • CDKN2A • MLH1 • MSH6 • MSH2 • BRCA • EPCAM • PRSS1
|
BRCA2 mutation • BRCA1 mutation • PALB2 mutation • CDKN2A mutation • MLH1 mutation • PMS2 mutation • BRCA mutation
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome (NCT05411718)
Phase 2
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Recruiting
Phase 2
M.D. Anderson Cancer Center
Recruiting
Last update posted :
03/13/2024
Initiation :
03/21/2023
Primary completion :
11/30/2025
Completion :
11/30/2025
MSI • MLH1 • MSH6 • MSH2
|
MSI-H/dMMR • MSH2 mutation • MLH1 mutation • PMS2 mutation
|
aspirin
GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study (NCT03751761)
Phase 1/2
Asan Medical Center
Asan Medical Center
Completed
Phase 1/2
Asan Medical Center
Completed
Last update posted :
02/28/2024
Initiation :
06/11/2018
Primary completion :
08/30/2023
Completion :
08/30/2023
PD-L1 • MSI • POLE • MLH1 • MSH6 • MSH2 • POLD1 • MSH3 • PMS1 • POLD2
|
MSI-H/dMMR • MSH2 mutation • MLH1 mutation • PD-L1 amplification • POLD1 mutation • MSH3 mutation • PMS2 mutation • MLH3 mutation • PMS1 mutation • POLD2 mutation
|
Imfinzi (durvalumab) • paclitaxel • Imjudo (tremelimumab)
Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis (NCT06206083)
Phase N/A
National Institute of Cancerología
National Institute of Cancerología
Recruiting
Phase N/A
National Institute of Cancerología
Recruiting
Last update posted :
02/28/2024
Initiation :
03/01/2024
Primary completion :
11/01/2026
Completion :
02/01/2027
TP53 • MSI • POLE • MLH1 • MSH6 • MSH2
|
POLE mutation • MLH1 mutation
Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes (NCT02371135)
Phase N/A
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Active, not recruiting
Phase N/A
Memorial Sloan Kettering Cancer Center
Active, not recruiting
Last update posted :
02/02/2024
Initiation :
02/01/2015
Primary completion :
02/01/2025
Completion :
02/01/2025
STK11 • MLH1 • MSH6 • MSH2 • SMAD4 • APC • EPCAM • BMPR1A
|
MSH2 mutation • MLH1 mutation • PMS2 mutation
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients, CORAL Study (NCT05410977)
Phase N/A
Mayo Clinic
Mayo Clinic
Recruiting
Phase N/A
Mayo Clinic
Recruiting
Last update posted :
01/18/2024
Initiation :
03/30/2022
Primary completion :
04/01/2025
Completion :
04/01/2026
MLH1 • MSH6 • MSH2 • EPCAM
|
MSH2 mutation • MLH1 mutation • PMS2 mutation
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible) (NCT02993068)
Phase N/A
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Recruiting
Phase N/A
M.D. Anderson Cancer Center
Recruiting
Last update posted :
01/17/2024
Initiation :
04/18/2017
Primary completion :
04/18/2024
Completion :
04/18/2024
ER • PGR • BRCA1 • BRCA2 • MLH1 • MSH6 • MSH2 • BRIP1 • RAD51C • RAD51D • BARD1
|
BRCA2 mutation • BRCA1 mutation • PALB2 mutation • BRIP1 mutation • MSH2 mutation • RAD51C mutation • MLH1 mutation • RAD51D mutation • PMS2 mutation • BARD1 mutation • RAD51 mutation
Cycling in Preventing Colorectal Cancer in Participants With Lynch Syndrome (NCT03495674)
Phase N/A
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Completed
Phase N/A
M.D. Anderson Cancer Center
Completed
Last update posted :
01/05/2024
Initiation :
04/04/2018
Primary completion :
01/02/2024
Completion :
01/02/2024
MSI • MLH1 • MSH6 • MSH2 • EPCAM
|
MSI-H/dMMR • MSH2 mutation • MLH1 mutation • PMS2 mutation
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer (NCT05013216)
Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Cent...
Recruiting
Phase 1
Sidney Kimmel Comprehensive Cancer Center at Jo...
Recruiting
Last update posted :
09/04/2023
Initiation :
04/11/2022
Primary completion :
05/01/2026
Completion :
05/01/2026
KRAS • BRCA1 • BRCA2 • ATM • CDKN2A • CD8 • MLH1 • MSH6 • MSH2 • CD4 • EPCAM • PMS1
|
KRAS mutation • PALB2 mutation • CDKN2A mutation • MLH1 mutation • PMS1 mutation
|
Hiltonol (poly-ICLC) • KRAS peptide vaccine
CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch Syndrome (CADLYNCH) (NCT05963191)
Phase N/A
PERROD Guillaume
PERROD Guillaume
Not yet recruiting
Phase N/A
PERROD Guillaume
Not yet recruiting
Last update posted :
07/27/2023
Initiation :
10/02/2023
Primary completion :
10/02/2023
Completion :
10/02/2025
MSH2
|
MSH2 mutation • MLH1 mutation • PMS2 mutation
Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL) (NCT03434158)
Phase 2
Spanish Oncology Genito-Urinary Group
Spanish Oncology Genito-Urinary Group
Completed
Phase 2
Spanish Oncology Genito-Urinary Group
Completed
Last update posted :
11/03/2022
Initiation :
02/06/2018
Primary completion :
05/12/2022
Completion :
05/12/2022
BRCA1 • BRCA2 • HRD • MLH1 • MSH6 • MSH2 • CHEK2 • RAD51C
|
CHEK2 mutation • MLH1 mutation
|
Lynparza (olaparib) • docetaxel
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (MesaCAPP) (NCT04920149)
Phase 2
Ann-Sofie Backman
Ann-Sofie Backman
Recruiting
Phase 2
Ann-Sofie Backman
Recruiting
Last update posted :
03/28/2022
Initiation :
03/21/2022
Primary completion :
10/15/2028
Completion :
10/15/2038
MLH1 • MSH6 • MSH2 • EPCAM
|
MSH2 mutation • MLH1 mutation
the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer (NCT05131243)
Phase N/A
Fujian Cancer Hospital
Fujian Cancer Hospital
Not yet recruiting
Phase N/A
Fujian Cancer Hospital
Not yet recruiting
Last update posted :
11/23/2021
Initiation :
12/01/2021
Primary completion :
05/01/2023
Completion :
05/01/2023
MLH1 • MSH6 • MSH2 • EPCAM
|
MSH2 mutation • MLH1 mutation • PMS2 mutation • MLH3 mutation
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome (NCT02052908)
Phase 1
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Completed
Phase 1
National Cancer Institute (NCI)
Completed
Last update posted :
01/25/2021
Initiation :
01/27/2014
Primary completion :
10/25/2019
Completion :
01/05/2021
MSI • MLH1 • MSH6 • MSH2
|
MSI-H/dMMR • MLH1 mutation • PMS2 mutation
Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy (NCT03631641)
Phase 2
Joanne Jeter
Joanne Jeter
Unknown status
Phase 2
Joanne Jeter
Unknown status
Last update posted :
05/15/2020
Initiation :
08/21/2018
Primary completion :
12/31/2020
Completion :
12/31/2020
MLH1 • MSH2
|
MSH2 mutation • MLH1 mutation
|
Opdivo (nivolumab)
Naproxen for Lynch Syndrome (NCT02048735)
Phase 1
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Recruiting
Phase 1
M.D. Anderson Cancer Center
Recruiting
Last update posted :
12/12/2017
Initiation :
01/01/2014
Primary completion :
01/01/2021
MSI • MLH1 • MSH6 • MSH2
|
MSI-H/dMMR • MSH2 mutation • MLH1 mutation • PMS2 mutation
Prostate Cancer Screening Among Men With High Risk Genetic Predisposition (NCT02053805)
Phase N/A
Rabin Medical Center
Rabin Medical Center
Unknown status
Phase N/A
Rabin Medical Center
Unknown status
Last update posted :
10/17/2017
Initiation :
02/01/2014
Primary completion :
06/01/2018
Completion :
06/01/2019
BRCA1 • BRCA2 • MLH1 • MSH6 • MSH2 • BRCA
|
BRCA2 mutation • BRCA1 mutation • MSH2 mutation • MLH1 mutation • PMS2 mutation • BRCA mutation
The GEOLynch Cohort Study (NCT03303833)
Phase N/A
Wageningen University
Wageningen University
Recruiting
Phase N/A
Wageningen University
Recruiting
Last update posted :
10/06/2017
Initiation :
07/01/2006
Primary completion :
12/01/2030
Completion :
12/01/2030
MLH1 • MSH6 • MSH2 • EPCAM
|
MSH2 mutation • MLH1 mutation • PMS2 mutation
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome (NCT02864979)
Phase 2
Rabin Medical Center
Rabin Medical Center
Not yet recruiting
Phase 2
Rabin Medical Center
Not yet recruiting
Last update posted :
09/20/2017
Initiation :
08/01/2016
Primary completion :
07/01/2022
Completion :
07/01/2022
MLH1 • MSH6 • MSH2
|
MSH2 mutation • MLH1 mutation • PMS2 mutation
Psychosocial Aspects of Genetic Testing for Hereditary Nonpolyposis Colon Cancer (NCT00341575)
Phase N/A
National Human Genome Research Institute (NHGRI)
National Human Genome Research Institut...
Completed
Phase N/A
National Human Genome Research Institute (NHGRI)
Completed
Last update posted :
07/02/2017
Initiation :
09/28/2005
Completion :
08/02/2010
MSH2
|
MSH2 mutation • MLH1 mutation
Cancer Genetics Hereditary Cancer Panel Testing (NCT02324062)
Phase N/A
University of Southern California
University of Southern California
Completed
Phase N/A
University of Southern California
Completed
Last update posted :
04/11/2017
Initiation :
06/12/2014
Primary completion :
01/05/2017
Completion :
01/05/2017
PTEN • MLH1 • MSH6 • MSH2 • BRCA
|
MSH6 mutation • MLH1 mutation
Chromoendoscopy to Decrease the Risk of Colorectal Neoplasia in Lynch Syndrome (ChromoLynch) (NCT00905710)
Phase N/A
University Medical Center Groningen
University Medical Center Groningen
Completed
Phase N/A
University Medical Center Groningen
Completed
Last update posted :
05/13/2016
Initiation :
09/01/2008
Primary completion :
05/01/2016
Completion :
05/01/2016
MLH1 • MSH6 • MSH2
|
MSH6 mutation • MSH2 mutation • MLH1 mutation
Capsule Endoscopy to Screen for Small Bowel Neoplasia in Lynch Syndrome (CELSIUS) (NCT00898768)
Phase 1
University Medical Center Groningen
University Medical Center Groningen
Completed
Phase 1
University Medical Center Groningen
Completed
Last update posted :
12/09/2014
Initiation :
05/01/2009
Primary completion :
12/01/2014
Completion :
12/01/2014
MLH1 • MSH6 • MSH2
|
MSH2 mutation • MLH1 mutation
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login